Galapagos expands chemistry services through contracts with Indian companies

By E. Janene Geiss

Philadelphia, June 23 - Galapagos NV said Friday that its service division BioFocus DPI has signed collaborations with Indus Biosciences, a subsidiary of CiVentiChem LLC in Hyderabad, India, and ProCitius, a division of Sanmar Specialty Chemicals Ltd. in Chennai, India.

Both contract research companies are providers of integrated chemistry services to life sciences companies, according to a company news release.

The companies will carry out chemistry services for the BioFocus DPI discovery products division, with an option to provide support for client projects conducted by the BioFocus DPI medicinal chemistry division, officials said.

India offers chemistry capabilities with a large resource pool of qualified chemists, the company said.

Many pharmaceutical and biotechnology companies either have established their own facilities in India, or outsourced part of their chemistry to India-based contract research organizations.

This outsourcing enables BioFocus DPI and its partners to benefit from the excellent cost-effective chemistry services available on the Indian sub-continent, while also enabling its clients to outsource work into Indus BioSciences and Sanmar under the management of BioFocus DPI scientists.

"These strategic outsourcing agreements with CiVentiChem and Sanmar complement our acquisition of DPI's drug discovery operations," Onno van de Stolpe, chief executive officer of Galapagos, said in the release.

Galapagos is a Mechelen, Belgium, genomics-based drug discovery company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.